MX2011012069A - Micro-organismos no-replicantes y su efecto inmuno estimulador. - Google Patents

Micro-organismos no-replicantes y su efecto inmuno estimulador.

Info

Publication number
MX2011012069A
MX2011012069A MX2011012069A MX2011012069A MX2011012069A MX 2011012069 A MX2011012069 A MX 2011012069A MX 2011012069 A MX2011012069 A MX 2011012069A MX 2011012069 A MX2011012069 A MX 2011012069A MX 2011012069 A MX2011012069 A MX 2011012069A
Authority
MX
Mexico
Prior art keywords
bifidobacterium
organisms
present
probiotics
boosting effect
Prior art date
Application number
MX2011012069A
Other languages
English (en)
Inventor
Guenolee Prioult
Annick Mercenier
Sophie Nutten
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40848602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2011012069(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2011012069A publication Critical patent/MX2011012069A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)

Abstract

La presente invención se refiere de manera general al campo de las bacterias probióticas. En particular, la presente invención se refiere probióticos no-replicantes, tales como el género Lactobacillus, Bifidobacterium o combinaciones de los mismos, por ejemplo Lactobacillus paracasei, Lactobacillus rhamnosus, Bifidobacterium Ion gum, Bifidobacterium lactis, Bifidobacterium breve o combinaciones de as mismas, y aplicaciones de estas bacterias. Una modalidad de la presente invención se refiere a probióticos no-replicantes y su uso para preparar una composición para tratar o prevenir padecimientos relacionados con una defensa inmune comprometida. Se describe un método para incrementar la efectividad de los probióticos para tratar o prevenir padecimientos inmunes.
MX2011012069A 2009-05-11 2010-05-07 Micro-organismos no-replicantes y su efecto inmuno estimulador. MX2011012069A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09159929A EP2251022A1 (en) 2009-05-11 2009-05-11 Non-replicating micro-organisms and their immune boosting effect
PCT/EP2010/056287 WO2010130660A1 (en) 2009-05-11 2010-05-07 Non-replicating micro-organisms and their immune boosting effect

Publications (1)

Publication Number Publication Date
MX2011012069A true MX2011012069A (es) 2011-12-06

Family

ID=40848602

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011012069A MX2011012069A (es) 2009-05-11 2010-05-07 Micro-organismos no-replicantes y su efecto inmuno estimulador.

Country Status (14)

Country Link
US (1) US20120107290A1 (es)
EP (2) EP2251022A1 (es)
JP (1) JP2012526749A (es)
CN (1) CN102724987A (es)
AR (1) AR076862A1 (es)
AU (1) AU2010247467A1 (es)
BR (1) BRPI1011024A2 (es)
CA (1) CA2761442A1 (es)
CL (1) CL2011002852A1 (es)
MX (1) MX2011012069A (es)
RU (1) RU2011150187A (es)
TW (1) TW201103552A (es)
WO (1) WO2010130660A1 (es)
ZA (1) ZA201109087B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX338680B (es) 2009-05-11 2016-04-27 Nestec Sa Bifidobacterium longum ncc2705 (cncm i-2618) y padecimientos inmunes.
TWI406665B (zh) * 2010-09-01 2013-09-01 Genmont Biotech Inc 益生菌株ｇｍ－０８０用於製備治療心臟發炎與心臟細胞凋亡之醫藥組合物及其用途
EP2455094A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
EP2455093A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
LT2672980T (lt) * 2011-02-09 2018-03-12 Lavivo Ab Simbiozinės kompozicijos žarnyno mikrobiotos atkūrimui ir rekonstrukcijai
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
CA2891947A1 (en) * 2012-11-29 2014-06-05 Nestec S.A. Synbiotic composition and use thereof
CA2891860A1 (en) * 2012-11-29 2014-06-05 Nestec S.A. Synbiotic composition and use thereof
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
KR101640744B1 (ko) 2014-05-07 2016-07-19 일동제약주식회사 고분자 다당 바인더에 컨쥬게이트된 락토바실러스 람노서스 rht-3201, 및 이의 아토피 예방 및 치료 용도
SI3193901T1 (en) 2014-12-23 2018-06-29 4D Pharma Research Limited Pirin polypeptide and immune modulation
NO3065748T3 (es) 2014-12-23 2018-04-21
HUE044617T2 (hu) 2015-06-15 2019-11-28 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
SG10201912324XA (en) 2015-06-15 2020-02-27 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
ME03563B (me) 2015-06-15 2020-07-20 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
WO2017069163A1 (ja) * 2015-10-19 2017-04-27 株式会社明治 乳児向けの感染防御剤
CN108289919A (zh) * 2015-10-19 2018-07-17 株式会社明治 面向婴儿的抗过敏剂
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MD3209310T2 (ro) 2015-11-20 2018-06-30 4D Pharma Res Ltd Compoziții care conțin tulpini bacteriene
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
CN114712405A (zh) 2016-03-04 2022-07-08 4D制药有限公司 包含细菌菌株的组合物
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
AU2017240069B2 (en) 2016-03-31 2024-03-07 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
ES2657665B1 (es) * 2016-09-05 2018-12-17 Pedro Jose DE LA FUENTE BLASCO Productos para la salud con probióticos inactivados y uso de dichos productos
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
EP3630137B1 (en) 2017-05-22 2023-05-17 4D Pharma Research Limited Compositions comprising bacterial strains
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN107114794A (zh) * 2017-06-06 2017-09-01 上海真合生物技术有限公司 用于增强抗过敏能力的益生菌组合物
PL3600364T3 (pl) 2017-06-14 2021-01-11 4D Pharma Research Limited Kompozycje zawierające szczep bakteryjny z rodzaju megasphaera i ich zastosowania
SI3638271T1 (sl) 2017-06-14 2021-01-29 4D Pharma Research Limited Sestavki, ki vsebujejo bakterijske seve
JP2019208486A (ja) * 2018-06-08 2019-12-12 株式会社ブロマ研究所 乳酸菌含有組成物及び免疫賦活用組成物
US11497197B2 (en) * 2018-07-18 2022-11-15 University Of Connecticut Methods for enhancing poultry growth and performance
CN116916942A (zh) * 2020-12-17 2023-10-20 欣巴伦斯有限公司 益生菌组合物及其在预防和/或治疗应激相关病症中的用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
MXPA02007018A (es) * 2000-01-18 2002-12-13 Nestle Sa Composicion alimenticia para mascotas para tratamiento de la especie helicobacter en mascotas.
BRPI0114400B8 (pt) * 2000-10-06 2021-05-25 Nestle Sa uso de bactéria de ácido lático probiótica para equilibrar o sistema imunológico da pele
AU2003303894A1 (en) * 2003-01-30 2004-08-30 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
EP1722804B1 (en) * 2004-03-04 2015-01-21 E-L Management Corp. Skin treatment method with lactobacillus extract
JP5371169B2 (ja) * 2004-09-24 2013-12-18 コンビ株式会社 薬剤耐性菌感染防除剤
KR100578395B1 (ko) * 2005-11-11 2006-05-10 주식회사 바이오리더스 면역기능이 강화된 사균화 유산균 제제 및 그 제조방법
ES2381211T3 (es) * 2006-02-15 2012-05-24 Nestec S.A. Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
RU2468807C2 (ru) * 2007-02-28 2012-12-10 Мед Джонсон Нутришен Компани Детское питание, содержащее инактивированный пробиотик
JP2008245569A (ja) * 2007-03-30 2008-10-16 Kirin Holdings Co Ltd 高抗アレルギー活性を有する乳酸菌組成物及び該乳酸菌の製造方法
EP1992351B1 (en) * 2007-05-18 2016-05-11 Nestec S.A. Lactobacillus johnsonii for prevention of postsurgical infection
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control

Also Published As

Publication number Publication date
BRPI1011024A2 (pt) 2019-09-24
ZA201109087B (en) 2013-05-29
CN102724987A (zh) 2012-10-10
US20120107290A1 (en) 2012-05-03
RU2011150187A (ru) 2013-06-20
AU2010247467A1 (en) 2011-12-08
AR076862A1 (es) 2011-07-13
JP2012526749A (ja) 2012-11-01
CA2761442A1 (en) 2010-11-18
TW201103552A (en) 2011-02-01
WO2010130660A1 (en) 2010-11-18
CL2011002852A1 (es) 2012-07-20
EP2429547A1 (en) 2012-03-21
EP2251022A1 (en) 2010-11-17

Similar Documents

Publication Publication Date Title
MX2011012069A (es) Micro-organismos no-replicantes y su efecto inmuno estimulador.
UA111715C2 (uk) Композиція, що містить пробіотичні бактерії для застосування у лікуванні імунних розладів
NZ593708A (en) Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
PH12018502042A1 (en) Use of probiotics in the treatment and/or prevention of psoriasis
EP4257194A3 (en) Use of microbial communities for human and animal health
PH12019500123A1 (en) Use of probiotics in the treatment and/or prevention of atopic dermatitis
MY159273A (en) Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
IN2012DN01638A (es)
WO2007023226A3 (fr) Utilisation d'un symbiotique pour le traitement de la dermatite atopique
AR035761A1 (es) Bacterias de acido lactico como agentes para tratar y prevenir la alergia
WO2012149615A3 (en) Polybacterial preparation with health benefits: antioxidant effect, reduction of cholesterol concentration, anti-inflammatory immunomodulating effect and release of bioactive peptides inhibiting angiotensin-converting enzyme
ZA201804863B (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
HRP20130487A2 (hr) Formulacija probiotika s apigeninom i ekstraktom paprene metvice
MY158310A (en) Prevention and treatment of allergic diarrhoea
UA94056C2 (uk) Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій
MX2017007654A (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas.
MX2022008666A (es) Composicion probiotica para su uso como antioxidante.
ATE541468T1 (de) Mikrobielle futterergänzungsmittel und verwendungen davon in verfahren zur verringerung und/oder verhinderung von azidose in polygastrischen pflanzenfressern
LT2013502A (lt) Maistinio arba farmacinio biopreparato kompozicija
AR061534A1 (es) Procedimiento para eliminar salmonella de materia prima derivada de poroto de soja y composicion salmonellicida util en dicho procedimiento
UA89037U (uk) Кормова добавка з пробіотичною дією "пробіолакт"
PL406051A1 (pl) Zastosowanie kompozycji probiotycznej
BG66294B1 (en) Probiotic strain lactobacillus delbrueckii subsp. bulgaricus
UA116253C2 (uk) Спосіб одержання бактеріального концентрату "бк-птиця" для кормових продуктів
PL397178A1 (pl) Kompozycja probiotyczna

Legal Events

Date Code Title Description
FA Abandonment or withdrawal